Eun-Seok Jeon

Publications : 0
Aldex : 0
H-index : 0
Citations : 0


Discriminative Role of Invasive Left Heart Catheterization in Patients Suspected of Heart Failure With Preserved Ejection Fraction.

Ki Hong Choi, Eun-Seok Jeon et 15 al.

Mar 9, 2023 in Journal of the American Heart Association
Background Recently, diastolic stress testing and invasive hemodynamic measurements have been emphasized for diagnosis of heart failure with preserved ejection fraction (HFpEF) because when determined using noninvasive parameters it can fall into a nondiagnostic intermediate range. The current study evaluated the discriminative and prognostic roles of invasive measured left ventricular end-diasto...


The impact of preoperative kidney replacement therapy on kidney outcome and survival in patients with left ventricular assist device.

Hojin Jeon et 11 al.

Dec 1, 2023 in Renal failure
Left ventricular assist device (LVAD) has been highlighted as a new treatment option in the end-stage heart failure (HF). Kidney outcome after LVAD in severe cardiorenal syndrome (CRS) patients requiring kidney replacement therapy (KRT) is unclear. We investigated the impact of preoperative KRT on kidney function and survival in LVAD patients with severe CRS. A total of 50 patients followed up for...


Prognostic Implications of Left Atrial Stiffness Index in Heart Failure Patients With Preserved Ejection Fraction.

Darae Kim et 7 al.

Dec 1, 2022 in JACC. Cardiovascular imaging
The left atrium (LA) plays an important role in the pathophysiology and disease progression of heart failure with preserved ejection fraction (HFpEF). This study sought to assess the prognostic potential of LA stiffness index in patients who have HFpEF. This study retrospectively screened patients with elevated left ventricular end-diastolic pressure (≥16 mm Hg) and preserved ejection fraction (≥5...


Sex and age differences in sST2 in cardiovascular disease

Danielle J. Beetler et 16 al.

Jan 18, 2023 in Frontiers in Cardiovascular Medicine
Aims The goal of this study was to determine whether sex and age differences exist for soluble ST2 (sST2) for several cardiovascular diseases (CVDs). Method We examined sST2 levels using an ELISA kit for myocarditis (n = 303), cardiomyopathy (n = 293), coronary artery disease (CAD) (n = 239), myocardial infarct (MI) (n = 159), and congestive heart failure (CHF) (n = 286) and compared them to contr...

Left atrial reservoir strain as a novel predictor of new-onset atrial fibrillation in light-chain-type cardiac amyloidosis.

You-Jung Choi et 12 al.

Jan 13, 2023 in European heart journal. Cardiovascular Imaging
To investigate whether left arterial reservoir strain (LASr) could predict new-onset atrial fibrillation (NOAF) in patients with light-chain-type cardiac amyloidosis (ALCA). This study enrolled 427 patients with CA from two tertiary centres between 2005 and 2019. LASr was measured using a vendor-independent analysis programme. The primary outcome was NOAF. A total of 287 patients with ALCA were in...


C reactive protein and statins in heart failure with reduced and preserved ejection fraction

Jin Joo Park, Dong-Ju Choi et 14 al.

Dec 23, 2022 in Frontiers in Cardiovascular Medicine
Background High C reactive protein (CRP) levels are associated with poor outcomes of heart failure (HF), and statins are known to reduce CRP levels. We investigated the prognostic value of CRP and statin in patients with HF with reduced and preserved ejection fraction (EF). Method Altogether, 3,831 patients from the Korean Acute Heart Failure registry were included and stratified according to the ...

Physiologic Assessment of Microvascular Function in Patients With Cardiac Amyloidosis

Joo Myung Lee, Eun-Seok Jeon et 2 al.

Jun 9, 2016 in
The aim of the study is to evaluate coronary flow reserve (CFR), index of microcirculatory resistance (IMR), and proportion of overt microvascular disease, defined as depressed CFR as well as elevated IMR in patients with cardiac amyloidosis. The second objective of this study is to compare results of non-invasive test including serum light chain amount, Doppler echocardiography with 2D strain, an...

Immediate Release Versus Slow Release Carvedilol in Heart Failure

Suk-Keun Hong, Byung-Su Yoo et 12 al.

Jul 3, 2017 in
Assessment of clinical effect and treatment quality of immediate release carvedilol (IR) versus slow release carvedilol (SR) in patients with HFrEF

Comparison of mid-term clinical outcome in heart transplantation patients using mycophenolate mofetil vs. enteric-coated mycophenolate sodium.

Kina Jeon, Eun-Seok Jeon et 13 al.

Aug 23, 2022 in Frontiers in cardiovascular medicine
Mycophenolate mofetil (MMF) is a prodrug of mycophenolic acid (MPA) and a key immunosuppressant for improving graft survival in patients with heart transplantation (HTx). However, dose reduction or interruption is occasionally needed due to gastrointestinal (GI) side effects. Enteric-coated mycophenolate sodium (EC-MPS) is an alternative form of MPA delivery to improve GI tolerability. In the pres...